Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulatory effects of low-dose lidocaine on neutrophils during sepsis
2010-019345-26Phase 3Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of lidocaine in sepsis, sponsored by Universitätsklinikum Münster. Primary endpoint: Neutrophil rolling velocity on E-selectin and ICAM-1 at 6 hours. Started Mar 2010; status: completed.
02
Drugs
lidocaine
03
Conditions
sepsis
Beyond the preview
Go deeper on 2010-019345-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019345-26.